A recent article in the New England Journal of Medicine evaluating the results of an experiment on how to treat type 2 diabetes in children raises some interesting questions:
http://www.nejm.org/doi/full/10.1056/NEJMoa1109333?query=featured_home#t=articleBackground
The Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study found that metformin and Avandia were superior to other treatments in controlling the disease in kids.
I have two questions: Will Steve Nissen admit he was wrong, again? Also, will doctors start to use existing diagnostics that identify those who do not respond to metformin, at least in kids. Isn't that choosing wisely?
http://www.nejm.org/doi/full/10.1056/NEJMoa1109333?query=featured_home#t=articleBackground
The Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study found that metformin and Avandia were superior to other treatments in controlling the disease in kids.
I have two questions: Will Steve Nissen admit he was wrong, again? Also, will doctors start to use existing diagnostics that identify those who do not respond to metformin, at least in kids. Isn't that choosing wisely?
